Company Filing History:
Years Active: 1988
Title: Dov Kanner: Innovator in Biotechnology
Introduction
Dov Kanner is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the production of high molecular weight sodium hyaluronate. With a total of 3 patents to his name, Kanner's work has implications for various applications in medicine and cosmetics.
Latest Patents
Kanner's latest patents focus on a novel mutant microorganism, Streptococcus zooepidemicus HA-116 ATCC 39920. This microorganism is engineered to produce large amounts of high molecular weight hyaluronic acid. The invention outlines a method for obtaining such microorganisms and details a process for producing sodium hyaluronate. This process involves growing the microorganism under specific conditions in a nutrient medium that contains a sugar component as a carbon source. The sugar concentration is maintained between 0.2 and 10 grams per liter, with a pH level between 6.0 and 7.5. Additionally, the medium includes a magnesium ion concentration above 0.05 grams per liter. The sodium hyaluronate produced is purified through methods that involve precipitation, redissolving, and reprecipitating, resulting in a composition that is free from pyrogenicity and skin irritation.
Career Highlights
Dov Kanner is associated with Bio-Technology General Corporation, where he continues to innovate in the field of biotechnology. His work has not only advanced scientific understanding but also contributed to practical applications in various industries.
Collaborations
Kanner has collaborated with notable colleagues, including Abraham Nimrod and Benjamin Greenman. Their combined expertise has furthered the research and development of biotechnological solutions.
Conclusion
Dov Kanner's contributions to biotechnology, particularly in the production of high molecular weight sodium hyaluronate, highlight his role as an influential inventor. His innovative methods and collaborations continue to shape the future of the industry.